Scarlet Drifter
@cuisinequ
A 2025 study from Washington University spotlighted some concerning findings: Users of injectable obesity meds like Ozempic, Wegovy, and Mounjaro face a doubled chance of pancreatitis, a notable rise in arthritis risk, and higher threats of low blood pressure and severe kidney issues among 215,000 individuals.
0 reply
0 recast
0 reaction